Corcept Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Corcept Therapeutics using advanced sorting and filters.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-04 | $0.16 | $0.15 | 6.67 % |
| Q2 | 2025-07-31 | $0.29 | $0.20 | 45.0 % |
| Q1 | 2025-05-05 | $0.17 | $0.14 | 21.4 % |
| Q4 | 2025-02-26 | $0.26 | $0.37 | -29.7 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-04 | $207.64M | $218.79M | -5.10 % |
| Q2 | 2025-07-31 | $194.43M | $201.27M | -3.40 % |
| Q1 | 2025-05-05 | $157.21M | $177.93M | -11.6 % |
| Q4 | 2025-02-26 | $181.89M | $195.74M | -7.08 % |
Corcept Therapeutics (CORT) is scheduled to report earnings on February 25, 2026. The last reported earnings were for reported on November 4, 2025 for Q3.
The Actual EPS was $0.16, which beat the estimate of $0.15.
The Actual Revenue was $207.6M, which missed the estimate of $218.8M.
Browse earnings estimates, EPS, and revenue on all stocks.